JMP Securities Downgrades Uroplasty (UPI) to Market Perform
Tweet
Share
E-mailGet Alerts UPI Hot Sheet
Price: $1.22 --0%
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 25
Rating Summary:
2 Buy, 2 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 8 | New: 25
Join SI Premium – FREE
JMP Securities downgraded Uroplasty (NASDAQ: UPI) from Outperform to Market Perform.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
For an analyst ratings summary and ratings history on Uroplasty click here. For more ratings news on Uroplasty click here.
Shares of Uroplasty closed at $4.22 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Raymond James Downgrades Liquidia Technologies (LQDA) to Outperform
- DBS Group Downgrades Sea Ltd. (SE) to Hold
- Goldman Sachs Double Downgrades Tourmaline Oil Corp. (TOU:CN) (TRMLF) to Sell
Create E-mail Alert Related Categories
DowngradesRelated Entities
JMP SecuritiesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
